Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 879 of 1,261
  1. US 8410261

    Compositions and methods for inhibiting expression of a gene from the JC virus

    Alnylam Pharmaceuticals, Inc. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  2. US 8410078

    Composition and methods to treat cardiac diseases

    UNIVERSITY OF CONNECTICUT · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  3. US 8409632

    Product containing extract from Zanthoxylum avicennae (Lam.) DC., and preparation process and use thereof

    China Medical University · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  4. US 8410043

    Stabilized activin IIB receptor polypeptides and uses thereof

    Atara Biotherapeutics, Inc. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  5. US 8410054

    Methods for treating pain by inhibition of the SCN9A channel

    Xenon Pharmaceuticals Inc. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  6. US 8409858

    Modular functional peptides for the intracellular delivery of nanoparticles

    United States of America as represented by the Secretary of the Air Force · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  7. US 8409585

    Method for increasing performance of offspring

    JBS UNITED, INC. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  8. US 8409126

    Selective cytopheresis devices and related methods thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  9. US 8409566

    Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis

    Northwest Biotherapeutics, Inc. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  10. US 8410087

    Indole compound

    Takeda Pharmaceutical Company Limited · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  11. US 8410081

    Treatment of cystic fibrosis

    ACADEMISCH MEDISCH CENTRUM · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  12. US 8410121

    Methods of treating pulmonary hypertension

    LEXICON PHARMACEUTICALS, INC. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  13. US 8410093

    Cycloalkyl substituted pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  14. US 8409548

    Administration of growth factors for the treatment of CNS disorders

    The Regents of the University of California · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  15. US 8409602

    Sealants for fetal membrane repair

    Northwestern University · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  16. CA 2849366

    COMPOSITIONS ET PROCEDES POUR TRAITER LA PRESBYTIE, L'HYPERMETROPIE LEGERE ET L'ASTIGMATISME IRREGULIER

    ALLERGEN INC [US] · Granted Mar 28, 2013 · Expires Mar 23, 2033

    granted
  17. CA 2851492

    COMPOSITIONS OPHTALMIQUES EN GEL

    BAUSCH & LOMB [US] · Granted Mar 28, 2013 · Expires Mar 23, 2033

    granted
  18. US 8403910

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted
  19. US 8404862

    Ligand-conjugated monomers

    Alnylam Pharmaceuticals, Inc. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted
  20. US 8404222

    Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution

    Nektar Therapeutics · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted
  21. US 8404869

    Phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome

    MAZENCE INC. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted
  22. US 8404635

    Orally administered peptides synergize statin activity

    The Regents of the University of California · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted
  23. US 8404643

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted
  24. US 8404638

    Dimer VEGF antagonist formulations

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.